• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Genmab A/S(GMAB.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec30
Genmab Expects Multiple Pivotal Trial Readouts in 2026
16:51
DNB Carnegie lowers Genmab's target price to 1985 Danish Krone
05:43
Dec29
Genmab A/S Halts Clinical Development of Acasunlimab
13:17
Dec23
Genmab A/S stock reaches new high
21:40
Genmab A/S Acquires Merus Shares Leading to Executive Changes
03:26
Dec22
Genmab A/S Acquires Additional Ordinary Shares in Merus NV
22:16

Schedules & Filings

Schedules
Filings
Feb17
Earning Release(EST)

FY2025 Annual Earning Release

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.022 B, Net Income 401 M, EPS 0.646

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 925 M, Net Income 336 M, EPS 0.542

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
10.170
+148.05%
+5.990
ANGH
3.800
+63.79%
+1.480
ESHA
22.330
+55.29%
+7.950
SIDU
3.995
+49.63%
+1.320
NCL
0.2783
+43.45%
+0.084
RDACR
0.2493
+31.21%
+0.059
ESHAR
0.2216
+30.35%
+0.052
LRE
1.648
+27.71%
+0.357
VNDA
8.954
+27.37%
+1.924
ULY
3.475
+25.91%
+0.715
View More